The North America doxorubicin market is expected to grow from US$ 617.61 million in 2022 to US$ 888.89 million by 2028; it is estimated to grow at a CAGR of 6.3% from 2022 to 2028.
Various countries have introduced missions and programs for rapid and effective cancer treatment. For example, in 2020, the National Comprehensive Cancer Control Program provided funding, guidance, and technical assistance to help programs implement cancer prevention and control plans. In 2016, the US government launched Cancer Moonshot with three ambitious goals. It is about accelerating scientific discoveries related to cancer, facilitating collaboration, and improving data sharing. Moreover, in February 2022, the Cancer Moonshot Project highlighted new goals of reducing cancer mortality by at least 50% over the next 25 years and provided information about enhancing cancer patients' and their families' lives. Furthermore, government funding for cancer prevention in various countries offers significant growth opportunities for the market. In June 2020, the National Institutes of Health granted nearly US$ 3.5 million to the University of Missouri School of Medicine to study a pre-treatment for chemotherapy that could protect cancer patients from therapy-induced heart problems. Thus, with rising cancer prevalence and increasing government support as funding, guidance, and assistance, emerging countries are providing significant growth opportunities to manufacturers operating in the doxorubicin drug market across the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America doxorubicin market. The North America doxorubicin market is expected to grow at a good CAGR during the forecast period.
North America Doxorubicin Market Segmentation
The North America doxorubicin market is segmented based on drug formulation, application, distribution channel, and country. Based on drug formulation, the North America doxorubicin market is bifurcated into lyophilized powder and doxorubicin injection. The lyophilized powder segment dominated the market in 2022. Based on application, the North America doxorubicin market is segmented into breast cancer, kidney cancer, liver cancer, sarcoma, ovarian cancer, lung cancer, leukemia, multiple myeloma, and others. The breast cancer segment dominated the market in 2022. Based on distribution channel, the North America doxorubicin market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the market in 2022. Based on country, the North America doxorubicin market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US dominated the market in 2022.
Accord Healthcare; Baxter International Inc.; Cipla Inc.; Dr. Reddy's Laboratories; Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.); Meiji Holdings Co., Ltd.; Novartis AG; Pfizer Inc.; Sun Pharmaceutical Industries Ltd; and Zydus Cadila are among the leading companies in the North America doxorubicin market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 617.61 Million |
| Market Size by 2028 | US$ 888.89 Million |
| CAGR (2022 - 2028) | 6.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Drug Formulation
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
The North America Doxorubicin Market is valued at US$ 617.61 Million in 2022, it is projected to reach US$ 888.89 Million by 2028.
As per our report North America Doxorubicin Market, the market size is valued at US$ 617.61 Million in 2022, projecting it to reach US$ 888.89 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The North America Doxorubicin Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Doxorubicin Market report:
The North America Doxorubicin Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Doxorubicin Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Doxorubicin Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Doxorubicin Market
